HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

DooYoung Jung Selected Research

Acute Myeloid Leukemia (Acute Myelogenous Leukemia)

3/2023Integrative Analyses Reveal the Anticancer Mechanisms and Sensitivity Markers of the Next-Generation Hypomethylating Agent NTX-301.
11/2022The preclinical efficacy of the novel hypomethylating agent NTX-301 as a monotherapy and in combination with venetoclax in acute myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


DooYoung Jung Research Topics

Disease

2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2023 - 11/2022
1Neoplasms (Cancer)
03/2023

Drug/Important Bio-Agent (IBA)

2venetoclaxIBA
03/2023 - 11/2022
1DNA (Deoxyribonucleic Acid)IBA
03/2023